Normative comparison of patient-reported outcomes in patients with noninfectious uveitis

JAMA Ophthalmology

Volumn 131, Issue 2, 2013, Pages 219-225

  Naik, Rupali K ^a   Rentz, Anne M ^b   Foster, C Stephen ^c   Lightman, Susan ^d   Belfort, Rubens ^e   Lowder, Careen ^f   Whitcup, Scott M ^a   Kowalski, Jonathan W ^a   Revicki, Dennis A ^b  

^a ALLERGAN INC   (United States)

^b UNITED BIOSOURCE CORPORATION   (United States)

^c Massachusetts Eye Research and Surgery Institute   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^f LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

ADULT; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY ANALYSIS; SELF REPORT; SHORT FORM 36; UVEITIS; VISION;

EID: 84874025574     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/2013.jamaophthalmol.102     Document Type: Article

References (39)

1. Nussenblatt RB, Whitcup SM, Palestine AG. Uveitis Fundamentals and Clinical Practice. 3rd ed. St Louis, MO: Mosby; 2004.
2. Nussenblatt RB. The natural history of uveitis. Int Ophthalmol. 1990;14(5-6):303-308.
3. Durrani OM, Meads CA, Murray PI. Uveitis: a potentially blinding disease. Ophthalmologica. 2004;218(4):223-236.
4. Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80(4):332-336.
5. Anesi SD, Foster CS. Importance of recognizing and preventing blindness from juvenile idiopathic arthritis-associated uveitis. Arthritis Care Res (Hoboken). 2012; 64(5):653-657.
6. Murphy CC, Greiner K, Plskova J, Frost NA, Forrester JV, Dick AD. Validity of using vision-related quality of life as a treatment end point in intermediate and posterior uveitis. Br J Ophthalmol. 2007;91(2):154-156.
7. Hughes EH, Murphy CC, Dick AD. Visual function and quality of life in intermediate uveitis. Invest Ophthalmol Vis Sci. 2004;45:E-abstract 2691.
8. Linder M, Chang TS, Scott IU, et al. Validity of the Visual Function Index (VF-14) in patients with retinal disease. Arch Ophthalmol. 1999;117(12):1611-1616.
9. Mangione CM, Phillips RS, Lawrence MG, Seddon JM, Orav EJ, Goldman L. Improved visual function and attenuation of declines in health-related quality of life after cataract extraction. Arch Ophthalmol. 1994;112(11):1419-1425.
10. Mangione CM, Phillips RS, Seddon JM, et al. Development of the "Activities of Daily Vision Scale": a measure of visual functional status. Med Care. 1992; 30(12):1111-1126.
11. Revicki DA, Rentz AM, Harnam N, Thomas VS, Lanzetta P. Reliability and validity of the National Eye Institute Visual Function Questionnaire-25 in patients with agerelated macular degeneration. Invest Ophthalmol Vis Sci. 2010;51(2):712-717.
12. Steinberg EP, Tielsch JM, Schein OD, et al. The VF-14: an index of functional impairment in patients with cataract. Arch Ophthalmol. 1994;112(5):630-638.
13. Schiffman RM, Jacobsen G, Whitcup SM. Visual functioning and general health status in patients with uveitis. Arch Ophthalmol. 2001;119(6):841-849.
14. Orr P, Rentz AM, Margolis MK, et al. Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52(6):3354-3359.
15. Lowder C, Belfort R Jr, Lightman S, et al; Ozurdex HURON Study Group. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol. 2011;129(5):545-553.
16. Ferris FL III, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. 1982;94(1):91-96.
17. Mangione CM. NEI VFQ-25 Scoring Algorithm. Rockville, MD: National Eye Institute; 2000.
18. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD; National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119(7):1050-1058.
19. Wild D, Grove A, Martin M, et al; ISPOR Task Force for Translation and Cultural Adaptation. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005;8(2): 94-104.
20. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A Users Manual. Lincoln, RI: QualityMetric; 2003.
21. Ware JE, Kosinski M, Dewey JE, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Lincoln, RI: QualityMetric; 2003.
22. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271-292.
23. Walters SJ, Brazier JE. What is the relationship between the minimally important difference and health state utility values? the case of the SF-6D. Health Qual Life Outcomes. 2003;1:4.
24. EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199-208.
25. Kind P. The EuroQoL instrument: an index of health-related quality of life. In: Spiker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Vol 2. Philadelphia, PA: Lippincott-Raven; 1996:191-201.
26. Mangione CM, Berry S, Spritzer K, et al. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol. 1998;116(2):227-233.
27. Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD; NEI-VFQ Field Test Investigators. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). Arch Ophthalmol. 1998;116(11):1496- 1504.
28. Fryback DG, Dunham NC, Palta M, et al. US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Med Care. 2007;45(12):1162-1170.
29. Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey, 2005. http://meps.ahrq.gov/mepsweb/. Accessed October 15, 2011.
30. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
31. Hawkins BS, Miskala PH, Mangione CM, et al; Submacular Surgery Trials Research Group. Health- and vision-related quality of life among patients with ocular histoplasmosis or idiopathic choroidal neovascularization at enrollment in a randomized trial of submacular surgery: Submacular Surgery Trials report No. 5. Arch Ophthalmol. 2005;123(1):78-88.
32. Miskala PH, Hawkins BS, Mangione CM, et al; Submacular Surgery Trials Research Group. Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization: SST report No. 1. Arch Ophthalmol. 2003;121(4):531-539.
33. Globe DR, Wu J, Azen SP, Varma R; Los Angeles Latino Eye Study Group. The impact of visual impairment on self-reported visual functioning in Latinos: the Los Angeles Latino Eye Study. Ophthalmology. 2004;111(6):1141-1149.
34. Cahill MT, Stinnett SS, Banks AD, Freedman SF, Toth CA. Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration. Ophthalmology. 2005;112(1):144-151.
35. Marback RF, Maia OO Jr, Morais FB, Takahashi WY. Quality of life in patients with age-related macular degeneration with monocular and binocular legal blindness. Clinics (Sao Paulo). 2007;62(5):573-578.
36. Sugawara T, Hagiwara A, Hiramatsu A, Ogata K, Mitamura Y, Yamamoto S. Relationship between peripheral visual field loss and vision-related quality of life in patients with retinitis pigmentosa. Eye (Lond). 2010;24(4):535-539.
37. Hirneiss C, Schmid-Tannwald C, Kernt M, Kampik A, Neubauer AS. The NEI VFQ-25 vision-related quality of life and prevalence of eye disease in a working population. Graefes Arch Clin Exp Ophthalmol. 2010;248(1):85-92.
38. Globe D, Varma R, Azen SP, Paz S, Yu E, Preston-Martin S; Los Angeles Latino Eye Study Group. Psychometric performance of the NEI VFQ-25 in visually normal Latinos: the Los Angeles Latino Eye Study. Invest Ophthalmol Vis Sci. 2003; 44(4):1470-1478.
39. Rossi GC, Milano G, Tinelli C. The Italian version of the 25-item National Eye Institute Visual Function Questionnaire: translation, validity, and reliability. J Glaucoma. 2003;12(3):213-220.